The expression of ABCG2 protein is correlated with the expression of HER2 in breast cancer, suggesting that ABCG2 is not only a drug-resistance-related transporter but also a potential biomarker predicting the biological behaviour, clinical progression and prognosis of breast cancer [42]. The gene discussed is ERBB2; the disease is breast carcinoma.